How β-Lactamases Have Driven Pharmaceutical Drug Discovery
Authors:
- 1 January 1998
- book chapter
- Published by Springer Nature
- p. 71-98
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- Amino Acid Sequence Determinants of β-Lactamase Structure and ActivityJournal of Molecular Biology, 1996
- Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B β-lactamaseJournal of Antimicrobial Chemotherapy, 1996
- Molecular evolution of bacterial β-lactam resistanceChemistry & Biology, 1996
- Crystal Structure of 6α-(Hydroxymethyl)penicillanate Complexed to the TEM-1 β-Lactamase from Escherichia coli: Evidence on the Mechanism of Action of a Novel Inhibitor Designed by a Computer-Aided ProcessJournal of the American Chemical Society, 1996
- Design, Synthesis, and Evaluation of a Potent Mechanism-Based Inhibitor for the TEM .beta.-Lactamase with Implications for the Enzyme MechanismJournal of the American Chemical Society, 1995
- β-Lactamase mutations far from the active site influence inhibitor bindingBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- β-Lactamase stability of cefoxitin in comparison with other β-lactam compoundsDiagnostic Microbiology and Infectious Disease, 1983
- β-lactamase activity of renal dipeptidase against N-formimidoyl-thienamycinBiochemical and Biophysical Research Communications, 1982
- Comparative amino acid contents of purified β‐lactamases from enteric bacteriaFEBS Letters, 1970